Eagle Rock Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Hold
20,874
0.15% 88
2026
Q1
$1.27M Buy
20,874
+369
+2% +$21.5K 0.18% 89
2025
Q4
$1.11M Hold
20,505
0.16% 92
2025
Q3
$925K Sell
20,505
-319
-2% -$14.9K 0.14% 97
2025
Q2
$964K Hold
20,824
0.15% 94
2025
Q1
$1.27M Hold
20,824
0.22% 89
2024
Q4
$1.18M Sell
20,824
-23,364
-53% -$1.31M 0.2% 90
2024
Q3
$2.29M Buy
44,188
+8,996
+26% +$422K 0.38% 68
2024
Q2
$1.46M Sell
35,192
-29,735
-46% -$1.33M 0.26% 84
2024
Q1
$3.52M Buy
64,927
+15,778
+32% +$804K 0.65% 46
2023
Q4
$2.52M Sell
49,149
-39,937
-45% -$2.1M 0.52% 56
2023
Q3
$5.17M Sell
89,086
-88
-0.1% -$5.39K 1.17% 26
2023
Q2
$5.52M Sell
89,174
-1,738
-2% -$117K 1.19% 25
2023
Q1
$6.3M Sell
90,912
-768
-0.8% -$54.2K 1.45% 22
2022
Q4
$6.6M Sell
91,680
-399
-0.4% -$30.1K 1.52% 20
2022
Q3
$6.55M Sell
92,079
-5,623
-6% -$408K 1.71% 16
2022
Q2
$7.52M Sell
97,702
-16,640
-15% -$1.27M 1.84% 16
2022
Q1
$8.35M Sell
114,342
-46,284
-29% -$3.11M 1.77% 18
2021
Q4
$10M Buy
+160,626
New +$9.42M 1.92% 17

Other funds holding BMY

Eagle Rock Investment Company's BMY Position: Q2 2026 in Review

Eagle Rock Investment Company held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 20,874 shares worth $1.2M. The position accounts for 0.15% of the portfolio, ranked #88.

Eagle Rock Investment Company first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $10M in Q4 2021. 1,086 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Eagle Rock Investment Company held 20,874 shares of Bristol-Myers Squibb worth $1.2M as of Q2 2026.
  • Eagle Rock Investment Company left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.15% of Eagle Rock Investment Company's portfolio in Q2 2026, its #88 holding.
  • Eagle Rock Investment Company first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • Eagle Rock Investment Company's Bristol-Myers Squibb position peaked at $10M in Q4 2021.
  • 1,086 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.